Olema Oncology
152 employees
Biotech/Pharma
Public · $389.0M
Open positions (32)
Company details
Team Size152
IndustryBiotech/Pharma
Funding
Total raised
$389.0M
Last stage
Public
Investors
Total raised
$389.0M
Last stage
Public
Investors
Peter Kushner
Co-founder and Chief Scientific Officer of Olema Oncology, a clinical-stage biopharmaceutical company focused on targeted therapies for breast cancer.
Cyrus L. Harmon
Co-founder of Olema Oncology (formerly Olema Pharmaceuticals).
Sean P. Bohen
President and Chief Executive Officer of Olema Oncology; previously an executive at Genentech and AstraZeneca.
LinkedInNo applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.